Dipan Mehta, a member of NSE and BSE and Rajesh Baheti, MD of Crosseas Capital, share their views on market movement. On Vedanta-Cairn deal, Mehta says Vedanta has got the deal at reasonable valuations but minority shareholders of Cairn are seen losing out.